Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital

By Sam | January 31, 2018

The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products.
Source: BioSpace

Posted in BioPharma